BRIEF-Amgen, Immatics enter strategic collaboration to develop novel bispecific cancer immunotherapies
January 09, 2017 at 04:07 AM EST
* Amgen and Immatics enter strategic collaboration to develop novel bispecific cancer immunotherapies
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|